logo-loader
viewTodos Medical Ltd.

Todos Medical reveals positive clinical proof of concept data from its rapid coronavirus test

Todos Medical Ltd (OTCQB:TOMDF) CEO Gerald Commissiong tells Proactive the group has “positive clinical proof of concept data” from its lab-based rapid SARS-CoV-2 3CL protease diagnostic test in collaboration with its joint venture partner NLC Pharma.

Commissiong says now, the group is gathering additional clinical data to submit an emergency use authorization to the FDA for its lab-based test to be distributed through the company’s existing lab distribution channels.

Quick facts: Todos Medical Ltd.

Price: 0.0575 USD

OTCQB:TOMDF
Market: OTCQB
Market Cap: $11.61 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Todos Medical Ltd. named herein, including the promotion by the Company of Todos Medical Ltd. in any Content on the Site, the Company receives...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Mines and Money' get set for next event, discussing Biden, Gold and Rare...

Mines and Money event organiser Andrew Thake talks to Proactive London's Katie Pilbeam about some of the guests at the next event taking place from November 30th to December 3rd. Ross Beaty from Pan American Silver will be speaking as well as David Garofalo who now runs the Marshall Precious...

14 hours, 10 minutes ago

2 min read